Atripla

Medicinal product

(Invented) name

Atripla

Active substance (s)

Efavirenzas/Emtricitabinas/Tenofoviro dizoproksilis

Strength

600 mg/200 mg/245 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J05AR06, Emtricitabine, tenofovir disoproxil and efavirenz

Marketing authorisation holder

Gilead Sciences Ireland UC, Airija

Date of authorisation

2007-12-13

Date of renewal

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

10b

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
29577	32064	1032064	buteliukas	N30		Receptinis	EU/1/07/430/001	Netiekiama	-	-	No	-	-
37280	50902	1050902	buteliukas	N3x30		Receptinis	EU/1/07/430/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-31	Išregistruotas
2007-12-13	Registruotas